Phase III results reignite female sexual dysfunction controversy

A non-hormonal treatment for women with so-called hypoactive sexual desire disorder (HSDD) has completed late-stage clinical testing.

by
There are currently no treatments approved for hypoactive sexual desire disorder in pre-menopausal women. (Photograph: SPL)
There are currently no treatments approved for hypoactive sexual desire disorder in pre-menopausal women. (Photograph: SPL)

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package